| WKN: | 870980 |
| ISIN: | US7599161095 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Repligen Corporation-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 04. Dezember 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2007 | 2,05 | 4,12 | 100,98% |
| 2 | 2013 | 4,62 | 9,16 | 98,27% |
| 3 | 2020 | 81,50 | 153,20 | 87,98% |
| 4 | 2019 | 43,51 | 81,50 | 87,31% |
| 5 | 2014 | 9,16 | 16,40 | 79,04% |
| 6 | 2012 | 2,66 | 4,62 | 73,68% |
| 7 | 2005 | 1,98 | 3,38 | 70,71% |
| 8 | 2015 | 16,40 | 27,31 | 66,52% |
| 9 | 2021 | 153,20 | 229,70 | 49,93% |
| 10 | 2018 | 29,73 | 43,51 | 46,35% |
| 11 | 2010 | 2,63 | 3,38 | 28,52% |
| 12 | 2000 | 3,40 | 4,00 | 17,65% |
| 13 | 2003 | 2,60 | 3,00 | 15,38% |
| 14 | 2016 | 27,31 | 29,64 | 8,53% |
| 15 | 2023 | 158,64 | 166,20 | 4,77% |
| 16 | 2025 | 137,70 | 141,60 | 2,83% |
| 17 | 2009 | 2,56 | 2,63 | 2,73% |
| 18 | 2017 | 29,64 | 29,73 | 0,30% |
| 19 | 2002 | 2,80 | 2,60 | -7,14% |
| 20 | 2024 | 166,20 | 137,70 | -17,15% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2006 | 3,38 | 2,05 | -39,35% |
| 2 | 2008 | 4,12 | 2,56 | -37,86% |
| 3 | 2004 | 3,00 | 1,98 | -34,00% |
| 4 | 2022 | 229,70 | 158,64 | -30,94% |
| 5 | 2001 | 4,00 | 2,80 | -30,00% |
| 6 | 2011 | 3,38 | 2,66 | -21,30% |
| 7 | 2024 | 166,20 | 137,70 | -17,15% |
| 8 | 2002 | 2,80 | 2,60 | -7,14% |
| 9 | 2017 | 29,64 | 29,73 | 0,30% |
| 10 | 2009 | 2,56 | 2,63 | 2,73% |
| 11 | 2025 | 137,70 | 141,60 | 2,83% |
| 12 | 2023 | 158,64 | 166,20 | 4,77% |
| 13 | 2016 | 27,31 | 29,64 | 8,53% |
| 14 | 2003 | 2,60 | 3,00 | 15,38% |
| 15 | 2000 | 3,40 | 4,00 | 17,65% |
| 16 | 2010 | 2,63 | 3,38 | 28,52% |
| 17 | 2018 | 29,73 | 43,51 | 46,35% |
| 18 | 2021 | 153,20 | 229,70 | 49,93% |
| 19 | 2015 | 16,40 | 27,31 | 66,52% |
| 20 | 2005 | 1,98 | 3,38 | 70,71% |